Pannexin 1 in Rhabdomyosarcoma: Role in Pathogenesis and Progression & Mechanisms of Action.

Pannexin 1 在横纹肌肉瘤中的作用：在发病机制和进展中的作用

• 批准号: 468011
• 负责人: Cowan Kyle
• 金额: $ 4.37万
• 依托单位: Children's Hospital of Eastern Ontario Research Institute Inc
• 依托单位国家: 加拿大
• 项目类别: Operating Grants
• 财政年份: 2022
• 资助国家: 加拿大
• 起止时间: 2022-02-01 至 2024-02-01
• 项目状态: 已结题
• 来源: https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=468011&lang=en
• 关键词: Childhood And Young Adult; Oncogenes And Tumour Suppressors; Sarcoma; Tumour Progression And Metastasis

Rhabdomyosarcoma (RMS) is the most common soft tissue cancer in Canadian children. RMS is a skeletal muscle-derived soft-tissue sarcoma affecting children and adolescents. Management of RMS is challenging and the cure rate for metastatic RMS remains below

横纹肌肉瘤（RMS）是加拿大儿童中最常见的软组织癌。RMS是一种影响儿童和青少年的骨骼肌来源的软组织肉瘤。RMS的治疗具有挑战性，转移性RMS的治愈率仍然很低